{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:50:08Z","timestamp":1787946608770,"version":"build-2784847793"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T00:00:00Z","timestamp":1391472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Patients with common variable immunodeficiency (CVID) have reduced numbers and frequencies of dendritic cells (DCs) in blood, and there is also evidence for defective activation through Toll-like receptors (TLRs). Collectively, these observations may point to a primary defect in the generation of functional DCs. Here, we measured frequencies of plasmacytoid DCs (pDCs) and myeloid DCs (mDCs) in peripheral blood of 26 CVID patients and 16 healthy controls. The results show that the patients have reduced absolute counts of both subsets. However, the decreased numbers in peripheral blood were not reflected in reduced frequencies of CD34+ pDC progenitors in the bone marrow. Moreover, studies at the single cell level showed that DCs from CVID patients and healthy controls produced similar amounts of interferon-\u03b1 or interleukin-12 and expressed similar levels of activation markers in response to human cytomegalovirus and ligands for TLR-7 and TLR-9. The study represents the most thorough functional characterization to date, and the first to assess bone marrow progenitor output, of naturally occurring DCs in CVID. In conclusion, it seems unlikely that CVID is secondary to insufficient production of naturally occurring DCs or a defect in their signalling through TLR-7 or TLR-9.<\/jats:p>","DOI":"10.1111\/cei.12239","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T14:43:54Z","timestamp":1384785834000},"page":"439-448","source":"Crossref","is-referenced-by-count":22,"title":["Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9"],"prefix":"10.1093","volume":"175","author":[{"given":"E","family":"Taraldsrud","sequence":"first","affiliation":[{"name":"Department of Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway"},{"name":"K.G. Jebsen Center for Cancer Immunotherapy and K.G. Jebsen Inflammation Research Center, University of Oslo, Oslo, Norway"},{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Fevang","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway"},{"name":"Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Aukrust","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway"},{"name":"Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K H","family":"Beiske","sequence":"additional","affiliation":[{"name":"Department of Pathology, Oslo University Hospital Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Fl\u00f8isand","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oslo University Hospital Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Fr\u00f8land","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway"},{"name":"Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Rollag","sequence":"additional","affiliation":[{"name":"Department of Microbiology, University of Oslo and Oslo University Hospital Rikshospitalet, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Olweus","sequence":"additional","affiliation":[{"name":"Department of Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway"},{"name":"K.G. Jebsen Center for Cancer Immunotherapy and K.G. Jebsen Inflammation Research Center, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"2021122010014513300_cei12239-bib-0001","first-page":"54","article-title":"Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies expert committee for primary immunodeficiency","volume":"2","author":"Al-Herz","year":"2011","journal-title":"Front Immunol"},{"key":"2021122010014513300_cei12239-bib-0002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2249.1992.tb06934.x","article-title":"Raised serum neopterin levels in patients with primary hypogammaglobulinaemia; correlation to other immunological parameters and to clinical and histological features","volume":"89","author":"Aukrust","year":"1992","journal-title":"Clin Exp Immunol"},{"key":"2021122010014513300_cei12239-bib-0003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/ACI.0b013e32835914b9","article-title":"The many faces of the clinical picture of common variable immune deficiency","volume":"12","author":"Resnick","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0004","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s10875-010-9424-3","article-title":"B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease","volume":"30","author":"Mouillot","year":"2010","journal-title":"J Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0006","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1182\/blood-2007-11-124545","article-title":"Common variable immunodeficiency disorders: division into distinct clinical phenotypes","volume":"112","author":"Chapel","year":"2008","journal-title":"Blood"},{"key":"2021122010014513300_cei12239-bib-0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-385991-4.00002-7","article-title":"\u2018A rose is a rose is a rose,\u2019 but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011?","volume":"111","author":"Yong","year":"2011","journal-title":"Adv Immunol"},{"key":"2021122010014513300_cei12239-bib-0008","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1084\/jem.194.6.863","article-title":"Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens","volume":"194","author":"Kadowaki","year":"2001","journal-title":"J Exp Med"},{"key":"2021122010014513300_cei12239-bib-0009","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"2021122010014513300_cei12239-bib-0010","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1182\/blood-2004-04-1325","article-title":"Common variable immunodeficiency is associated with defective functions of dendritic cells","volume":"104","author":"Bayry","year":"2004","journal-title":"Blood"},{"key":"2021122010014513300_cei12239-bib-0011","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00011-007-7081-7","article-title":"Altered dendritic cell function in response to sera of common variable immunodeficiency patients","volume":"56","author":"Nourizadeh","year":"2007","journal-title":"Inflamm Res"},{"key":"2021122010014513300_cei12239-bib-0012","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2249.2004.02640.x","article-title":"Monocyte-derived dendritic cell responses in common variable immunodeficiency","volume":"138","author":"Scott-Taylor","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"2021122010014513300_cei12239-bib-0013","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2249.2006.03152.x","article-title":"Defective maturation of dendritic cells in common variable immunodeficiency","volume":"145","author":"Scott-Taylor","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2021122010014513300_cei12239-bib-0014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.clim.2004.12.007","article-title":"Deficient IL-12 and dendritic cell function in common variable immune deficiency","volume":"115","author":"Cunningham-Rundles","year":"2005","journal-title":"Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nri3149","article-title":"Transcriptional programming of the dendritic cell network","volume":"12","author":"Belz","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2021122010014513300_cei12239-bib-0016","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1073\/pnas.94.23.12551","article-title":"Dendritic cell ontogeny: a human dendritic cell lineage of myeloid origin","volume":"94","author":"Olweus","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122010014513300_cei12239-bib-0017","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00262-010-0833-1","article-title":"Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy","volume":"59","author":"Schreibelt","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"2021122010014513300_cei12239-bib-0018","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood-2006-06-031484","article-title":"Plasmacytoid DCs regulate recall responses by rapid induction of IL-10 in memory T cells","volume":"109","author":"Kvale","year":"2007","journal-title":"Blood"},{"key":"2021122010014513300_cei12239-bib-0019","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1182\/blood-2005-05-2016","article-title":"CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection","volume":"107","author":"Kvale","year":"2006","journal-title":"Blood"},{"key":"2021122010014513300_cei12239-bib-0020","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H","article-title":"Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12","volume":"31","author":"Krug","year":"2001","journal-title":"Eur J Immunol"},{"key":"2021122010014513300_cei12239-bib-0021","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaci.2004.04.035","article-title":"Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells: modulation by CpG oligodeoxynucleotides","volume":"114","author":"Farkas","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0022","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.0105-2896.2009.00881.x","article-title":"Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance","volume":"234","author":"Swiecki","year":"2010","journal-title":"Immunol Rev"},{"key":"2021122010014513300_cei12239-bib-0023","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2249.2006.03063.x","article-title":"Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-gamma gene","volume":"144","author":"Martinez-Pomar","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2021122010014513300_cei12239-bib-0024","doi-asserted-by":"crossref","first-page":"R1052","DOI":"10.1186\/ar1774","article-title":"Altered dendritic cell distribution in patients with common variable immunodeficiency","volume":"7","author":"Viallard","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2021122010014513300_cei12239-bib-0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clim.2007.12.007","article-title":"Selective deficits in blood dendritic cell subsets in common variable immunodeficiency and X-linked agammaglobulinaemia but not specific polysaccharide antibody deficiency","volume":"127","author":"Yong","year":"2008","journal-title":"Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0026","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.4049\/jimmunol.176.3.1978","article-title":"TLR9 activation is defective in common variable immune deficiency","volume":"176","author":"Cunningham-Rundles","year":"2006","journal-title":"J Immunol"},{"key":"2021122010014513300_cei12239-bib-0027","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaci.2009.05.019","article-title":"Toll-like receptor 7 and 9 defects in common variable immunodeficiency","volume":"124","author":"Yu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0028","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021122010014513300_cei12239-bib-0029","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1182\/blood.V88.10.3741.bloodjournal88103741","article-title":"Granulocytic and monocytic differentiation of CD34hi cells is associated with distinct changes in the expression of the PU.1-regulated molecules, CD64 and macrophage colony-stimulating factor receptor","volume":"88","author":"Olweus","year":"1996","journal-title":"Blood"},{"key":"2021122010014513300_cei12239-bib-0030","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.165.11.6037","article-title":"BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood","volume":"165","author":"Dzionek","year":"2000","journal-title":"J Immunol"},{"key":"2021122010014513300_cei12239-bib-0031","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2005-07-2709","article-title":"Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells","volume":"107","author":"Ito","year":"2006","journal-title":"Blood"},{"key":"2021122010014513300_cei12239-bib-0032","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/79747","article-title":"Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization","volume":"1","author":"Cella","year":"2000","journal-title":"Nat Immunol"},{"key":"2021122010014513300_cei12239-bib-0033","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q","article-title":"Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells","volume":"31","author":"Jarrossay","year":"2001","journal-title":"Eur J Immunol"},{"key":"2021122010014513300_cei12239-bib-0034","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)61689-6","article-title":"Plasmacytoid dendritic cells (natural interferon-alpha\/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions","volume":"159","author":"Farkas","year":"2001","journal-title":"Am J Pathol"},{"key":"2021122010014513300_cei12239-bib-0035","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/mi.2012.136","article-title":"Plasmacytoid dendritic cells are scarcely represented in the human gut mucosa and are not recruited to the celiac lesion","volume":"6","author":"Raki","year":"2013","journal-title":"Mucosal Immunol"},{"key":"2021122010014513300_cei12239-bib-0036","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2249.2008.03734.x","article-title":"Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes","volume":"154","author":"Velasquez-Lopera","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2021122010014513300_cei12239-bib-0037","first-page":"207","article-title":"Quantitative and functional evaluation of innate immune responses in patients with common variable immunodeficiency","volume":"21","author":"Trujillo","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0038","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1182\/blood.V98.8.2574","article-title":"Loss of blood CD11c(+) myeloid and CD11c(\u2013) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load","volume":"98","author":"Donaghy","year":"2001","journal-title":"Blood"},{"key":"2021122010014513300_cei12239-bib-0039","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s00134-011-2306-1","article-title":"Profound and persistent decrease of circulating dendritic cells is associated with ICU-acquired infection in patients with septic shock","volume":"37","author":"Grimaldi","year":"2011","journal-title":"Intens Care Med"},{"key":"2021122010014513300_cei12239-bib-0040","doi-asserted-by":"crossref","first-page":"e19872","DOI":"10.1371\/journal.pone.0019872","article-title":"Severe and persistent depletion of circulating plasmacytoid dendritic cells in patients with 2009 pandemic H1N1 infection","volume":"6","author":"Lichtner","year":"2011","journal-title":"PLOS ONE"},{"key":"2021122010014513300_cei12239-bib-0041","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/hep.20306","article-title":"Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease","volume":"40","author":"Wertheimer","year":"2004","journal-title":"Hepatology"},{"key":"2021122010014513300_cei12239-bib-0042","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2249.2005.02994.x","article-title":"Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response","volume":"143","author":"Lichtner","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"2021122010014513300_cei12239-bib-0043","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1002\/art.11225","article-title":"Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus","volume":"48","author":"Blomberg","year":"2003","journal-title":"Arthritis Rheum"},{"key":"2021122010014513300_cei12239-bib-0044","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/ard.2009.118158","article-title":"Levels of plasmacytoid dendritic cells and type-2 myeloid dendritic cells are reduced in peripheral blood of patients with primary Sjogren's syndrome","volume":"69","author":"Vogelsang","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2021122010014513300_cei12239-bib-0045","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar1864","article-title":"Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis","volume":"8","author":"Jongbloed","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"2021122010014513300_cei12239-bib-0046","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/gut.2004.040360","article-title":"Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells","volume":"54","author":"Baumgart","year":"2005","journal-title":"Gut"},{"key":"2021122010014513300_cei12239-bib-0047","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clim.2008.08.013","article-title":"Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood","volume":"129","author":"Chen","year":"2008","journal-title":"Clin Immunol"},{"key":"2021122010014513300_cei12239-bib-0048","doi-asserted-by":"crossref","first-page":"e1000413","DOI":"10.1371\/journal.ppat.1000413","article-title":"Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection","volume":"5","author":"Brown","year":"2009","journal-title":"PLOS Pathog"},{"key":"2021122010014513300_cei12239-bib-0049","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1084\/jem.20110654","article-title":"Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo","volume":"208","author":"Swiecki","year":"2011","journal-title":"J Exp Med"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12239","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/175\/3\/439\/41789091\/cei12239.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/175\/3\/439\/41789091\/cei12239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:34Z","timestamp":1641054334000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/175\/3\/439\/6421177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,2,4]]},"published-print":{"date-parts":[[2014,2,4]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12239","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,3]]},"published":{"date-parts":[[2014,2,4]]}}}